Batoclimab vs Placebo for Generalized Myasthenia Gravis

This randomized clinical trial investigates the effectiveness and safety of the neonatal fragment crystallizable receptor monoclonal antibody, batoclimab, in adults with generalized myasthenia gravis.
Source: JAMA Neurology - Category: Neurology Source Type: research